Efficacy and safety of oral propranolol and topical timolol in the treatment of infantile hemangioma: a meta-analysis and systematic review
BackgroundPropranolol, a nonselective β-blocker, is the first-line treatment for infantile hemangioma (IH). Topical timolol has recently been proposed as a novel IH treatment with fewer adverse effects. This study was conducted to compare the efficacy and safety of oral propranolol and topical timol...
Saved in:
| Main Authors: | Xiaoye Huang, Wenyue Si, Zhili Zou, Binyao Li, Yide Mu, Wei Zhong, Kaiying Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1515901/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety assessment of propranolol tablets vs. oral solution for infantile hemangioma: a retrospective study in China
by: Wenting Chen, et al.
Published: (2025-02-01) -
Treatment of infantile hemangioma with topical β-blockers in pediatric practice: a review of the literature
by: O.V. Bogomolets, et al.
Published: (2023-12-01) -
Efficacy and safety of propranolol tablets vs. oral solution in neonates with severe infantile hemangiomas: a retrospective study in China
by: Zhiping Wu, et al.
Published: (2025-01-01) -
Neurodevelopmental Effects of Propranolol Treatment During Infancy in Infantile Hemangioma Patients
by: Cenk Baykan, et al.
Published: (2024-12-01) -
Evaluation of Five Ready-to-Use Bases for the Topical Administration of Propranolol Hydrochloride to Treat Infantile Hemangioma
by: Chiara Lacassia, et al.
Published: (2025-01-01)